Skip to content

English
Français

Careers
Contact Us

About DBV
- Overview
- Leadership
Our Pipeline
- Overview
- Clinical Trials
- VIASKIN^® peanut patch
- VIASKIN^® milk patch
- VIASKIN^® milk patch for EoE
- Expanded Access Program
Our Science
Investors
Newsroom
- Press Releases
- Media Kit

News

News

Select Year
Search News

Found 502 Results

Page 11 of 51« First «...9 101112 13...20 30 40...»Last »

October 5, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2023

September 5, 2023

DBV Technologies to Participate in Upcoming Investor Conference

July 31, 2023

DBV Technologies Receives Feedback from FDA on Design Elements for Viaskin Peanut Safety Studies and Reports Second Quarter and Half-Year 2023 Financial Results

July 25, 2023

DBV Technologies to Report First Half 2023 Financial Results and Provide a Corporate Update

July 19, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of June 30, 2023

July 10, 2023

Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF

June 16, 2023

Monthly information regarding the total number of voting rights and total number of shares of the Company as of May 31, 2023

June 8, 2023

DBV Technologies to Participate in Upcoming EAACI Congress 2023

June 6, 2023

DBV Technologies to Participate in Upcoming Investor Conference

May 10, 2023

DBV Technologies Announces New England Journal of Medicine Publication of Phase 3 EPITOPE Trial Data Evaluating Viaskin™ Peanut in Toddlers

Page 11 of 51« First «...9 101112 13...20 30 40...»Last »

Investor Relations Contact

Jonathan Neely

+1 848-388-4584

jonathan.neely@dbv-technologies.com

Media Contact

Brett Whelan

+1 848-350-7622

brett.whelan@dbv-technologies.com

Subscribe to get the latest DBV press releases

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

About DBV
- Overview
- Leadership
Our Pipeline
Our Science
Investors
News
Careers
Contact Us
English
Français

Homepage
About DBV
Our Pipeline
Our Science
News
Investors
Careers
Contact Us

© 2026 DBV Technologies. All rights reserved.
Les traitements de DBV Technologies sont expérimentaux et ne sont pas approuvés par la FDA.

Terms of Use
Privacy Policy
Legal Notice
Cookies Policy

Scroll to Top